store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Paltimatrectinib (PBI-200) is a potent tyrosine kinase inhibitor with anticancer activity that inhibits myosin-related kinase A (TrkA).Paltimatrectinib is used in the study of bladder, breast and colorectal cancers.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約8-10 週間 | ¥ 282,500 |
50 mg | 約8-10 週間 | ¥ 369,500 |
100 mg | 約8-10 週間 | ¥ 574,000 |
説明 | Paltimatrectinib (PBI-200) is a potent tyrosine kinase inhibitor with anticancer activity that inhibits myosin-related kinase A (TrkA).Paltimatrectinib is used in the study of bladder, breast and colorectal cancers. |
別名 | PBI-200, PPI-5278 |
分子量 | 434.37 |
分子式 | C20H15F5N6 |
CAS No. | 2353522-15-1 |
store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (23.02 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Paltimatrectinib 2353522-15-1 Tyrosine Kinase/Adaptors Trk receptor Tyrosine Kinases PBI-200 PPI-5278 Inhibitor inhibitor inhibit